Skip to main content

UPS Mobilizes Against Coronavirus In Collaboration With Global Customers And U.S. Agencies

ATLANTA, March 30, 2020 (GLOBE NEWSWIRE) —Working with global companies to transport testing kits, personal protection equipment (PPE) and medical devices needed in support of public safety and to speed diagnosis and therapy for COVID-19Supporting FEMA, Project Airbridge, and other government agencies with supply chain and shipping services for respirators, test kits, and PPE across the U.S.Helping U.S. state health agencies secure needed supplies and set up testing sites at state-designated locationsUPS is also working with Henry Schein, McKesson, and other valued customers to facilitate movement of PPE and other needed materials from suppliers to testing centers and distributors all over the US Assisting DuPont, and numerous other companies such as Uline, Grainger and Taylor Corporation, with the logistics and transportation of supplies for drive-through test centersDistributing critical, life-saving medications to physician offices, health systems and veterinary clinics in support of AmerisourceBergenMoving new FDA approved rapid-response test kits to test sites across the country to help flatten the curve of the virus’s impactUPS (NYSE:UPS) today announced an unprecedented increase in efforts in coordination with the President’s Coronavirus Taskforce, the Federal Emergency Management Agency (FEMA), and State health agencies. UPS Healthcare and UPS operations all over the world are working with many companies and agencies across the public and private sectors.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.